NEW YORK (GenomeWeb) – Quanterix reported after the close of the market on Wednesday that its first quarter revenues were up 41 percent year over year.

The company posted Q1 revenues of $7.5 million, up from $5.3 million in Q1 2017 and above the consensus Wall Street estimate of $7.1 million.

Q1 product revenues rose 38 percent to $4.7 million in Q1 2018 from $3.4 million in Q1 2017, thanks largely to sales of consumables. Service and other revenues rose 52 percent to $2.5 million from $1.6 million in the prior-year first quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

Aug
23
Sponsored by
Tecan

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.